✦ LIBER ✦

Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond

✍ Scribed by Teh-Ia Huo; Shou-Dong Lee; Han-Chieh Lin

Book ID: 111237883
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 105 KB
Volume: 28
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2008.01727.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of four model for end-stage l

Comparison of four model for end-stage liver disease–based prognostic systems for cirrhosis

✍ Teh-Ia Huo; Han-Chieh Lin; Samantha C. Huo; Pui-Ching Lee; Jaw-Ching Wu; Fa-Yauh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Serum sodium (Na) has been suggested for incorporation into the Model for End-Stage Liver Disease (MELD) to enhance its prognostic ability for patients with cirrhosis. Three Na-containing models--the Model for End-Stage Liver Disease with the incorporation of serum sodium (MELD-Na), the integrated M

Selecting an optimal cutoff value for cr

Selecting an optimal cutoff value for creatinine in the model for end-stage liver disease equation

✍ Teh-Ia Huo; Chia-Yang Hsu; Han-Chieh Lin; Pui-Ching Lee; Jing-Yi Lee; Fa-Yauh Le 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Model for end-stage liver disease, model

Model for end-stage liver disease, model for end-stage liver disease-sodium and Child–Turcotte–Pugh scores over time for the prediction of complications of liver cirrhosis

✍ Pil Cho Choi; Hong Joo Kim; Woo Hyuk Choi; Dong Il Park; Jung Ho Park; Yong Kyun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Model for end-stage liver disease except

Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system

✍ Claire Francoz; Jacques Belghiti; Denis Castaing; Olivier Chazouillères; Jean-Ch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not signific

The model for end-stage liver disease (M

The model for end-stage liver disease (MELD)

✍ Patrick S. Kamath; W. Ray Kim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

The Model for End-stage Liver Disease (MELD) was initially created to predict survival in patients with complications of portal hypertension undergoing elective placement of transjugular intrahepatic portosystemic shunts. The MELD which uses only objective variables was validated subsequently as an

Clinically relevant differences in the M

Clinically relevant differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease–sodium scores

✍ Rhiana Garritsen; Andrei Tintu; Herold Metselaar; Geert Kazemier 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views

With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant